TrustMF Multi Cap Fund
The scheme seeks to generate long-term capital appreciation by predominantly investing in a diversified portfolio of equity & equity related instruments across large cap, mid cap and small cap stocks.
Growthvine rating: 2/5 — ranked #28 of 35 in category.
Fund basics
| Category | Equity: Multi Cap |
|---|
| NAV | ₹10.87 (as of 2026-10-23) |
|---|
| AUM | ₹914 Cr |
|---|
| Expense ratio | 1.96% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Aakash Manghani |
|---|
| Exit load | 1% for redemption within 180 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −13.27% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 149.5% of NIFTY500 Multicap 50:25:25's upside and — of its downside.
Market cap allocation
| Large cap | 32.9% |
|---|
| Mid cap | 28.8% |
|---|
| Small cap | 38.3% |
|---|
Concentration
| Top 5 holdings | 14.1% |
|---|
| Top 10 holdings | 23.8% |
|---|
| Total holdings | 72 |
|---|
| Index overlap | 24.2% |
|---|
| Active share | 75.8% |
|---|
Top holdings
- TREPS 01-Oct-2026 — 7.8%
- ICICI Bank Ltd. — 4.0%
- Multi Commodity Exchange of India Ltd — 2.7%
- Eternal Limited — 2.6%
- Lenskart Solutions Limited — 2.5%
- Dixon Technologies (India) Limited — 2.2%
- Aurobindo Pharma Ltd. — 2.0%
- Titan Company Limited — 2.0%
- Laurus Labs Limited — 2.0%
- Kotak Mahindra Bank Ltd. — 2.0%
Top sectors
- Banking & Financial — 18.3%
- Pharma & Biotech — 9.7%
- Automobile — 8.6%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 3.8% | Q1 (Top) | #4 of 34 |